Overview

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study will measure serum levels of the active Vitamin D compound that circulates in hemodialysis subjects treated with either doxercalciferol injection (Hectorol®) or Zemplar® (paricalcitol injection).
Phase:
Phase 4
Details
Lead Sponsor:
Genzyme, a Sanofi Company
Treatments:
1 alpha-hydroxyergocalciferol
Ergocalciferols